Neuropeptide Semax: Cognitive Enhancement

By Cocer Peptides      22 days ago

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.

Cognitive impairment is a group of disorders that affect brain cognitive function, including symptoms such as memory loss, difficulty concentrating, and decreased thinking ability, which severely impact patients' quality of life. Neuropeptide Semax, as a substance with multiple regulatory effects on the nervous system, is helpful in treating epilepsy, improving cognitive function, and alleviating acute stress.

Figure 1 The chemical structure of Semax.

Overview of Neuropeptide Semax

Semax is a synthetic heptapeptide with the chemical structure Met - Glu - His - Phe - Pro - Gly - Pro. It is an analog of the 4-10 fragment of adrenocorticotropic hormone (ACTH) and can interact with specific receptors in the central nervous system to exert a series of biological effects. Due to its direct action on the central nervous system and lack of hormonal activity, it has laid the foundation for its application in the field of neuroscience.

Mechanism of Action of Neuropeptide Semax on Cognitive Function

Regulation of Neurotransmitter Systems: Semax may improve cognitive function by influencing the release, synthesis, or metabolism of neurotransmitters. It can regulate the levels of neurotransmitters such as dopamine and acetylcholine. Dopamine plays a key role in cognitive processes such as attention, learning, and memory. Semax may promote the activity of dopaminergic neurons, increase dopamine release, and thereby enhance the brain's ability to process and integrate information. Acetylcholine is a neurotransmitter closely associated with learning and memory. Semax may improve the function of the cholinergic nervous system by regulating the synthesis or release of acetylcholine, thereby enhancing cognitive function.

Promoting neurogenesis: Semax can stimulate the proliferation and differentiation of neural stem cells, promoting the generation of new neurons. In brain regions such as the hippocampus, which are closely associated with learning and memory, the generation of new neurons is crucial for maintaining normal cognitive function. Semax may promote neurogenesis in the hippocampus by activating specific signaling pathways, such as the Wnt/β-catenin signaling pathway, which plays a key role in the proliferation, differentiation, and survival of neural stem cells, thereby providing a structural foundation for cognitive enhancement.

Figure 2 The Potency of Semax Peptide Therapy toward MDA Level and Protein Profile in Epilepsy Rats (Rattus norvegicus). M is marker; A is Group A (negative control); B is group B (positive control); and C is group C (semax peptide therapy).

Antioxidant effects: Oxidative stress plays a significant role in neurodegenerative diseases and cognitive decline. Semax possesses antioxidant properties, enabling it to scavenge excess free radicals in the body and reduce oxidative damage to neurons. For example, by enhancing the activity of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and reducing the levels of oxidative products like malondialdehyde (MDA), it protects the integrity of neuronal membranes and maintains normal neuronal function, thereby indirectly contributing to improved cognitive function.

Regulating gene expression: Semax can influence the expression of genes related to cognitive function. It may upregulate the gene expression of certain neurotrophic factors and their receptors, such as brain-derived neurotrophic factor (BDNF) and its receptor TrkB. BDNF is crucial for neuronal survival, differentiation, synaptic plasticity, and learning and memory processes. Semax enhances cognitive function by promoting BDNF expression, thereby strengthening neuronal connections and signal transmission.

Applications of the neuropeptide Semax in cognitive enhancement

Preclinical studies

Animal experiments: In numerous animal experiments, Semax demonstrated significant cognitive-enhancing effects. In the Morris water maze test, rats treated with Semax were able to locate the hidden platform more quickly and spent more time in the target quadrant during the memory testing phase, indicating improved spatial learning and memory abilities. In the novel object recognition test, animals treated with Semax exhibited a significant increase in exploration time for new objects, indicating improved object recognition memory. These experimental results suggest that Semax can effectively enhance animals' learning and memory abilities.

Cell experiments: At the cellular level, Semax has a positive impact on neuronal cell survival, proliferation, and differentiation. Cultured neuronal cells exposed to oxidative stress or other damaging factors showed significantly improved cell survival rates when treated with Semax, promoting neuronal axon growth and branching, and enhancing neuronal connections. These cellular experiment results provide a cellular basis for Semax's cognitive-enhancing effects at the whole-animal level.

Figure 3 Micrograph of hippocampal dentate area sections immunohistochemically stained with antibodies against the Ki-67 protein: (a) 14-day-old KM rat injected with Semax on days 7–11 after birth and (b) intact 14-day-old KM rat. Scale, 100 µm.

Clinical application exploration

Cognitive impairments associated with neurological disorders: For certain neurological disorders, such as Alzheimer's disease and Parkinson's disease, which are accompanied by cognitive impairments, Semax holds potential therapeutic value. In some small-scale clinical trials, patients with mild to moderate Alzheimer's disease who received Semax treatment for a period of time showed improvements in memory, attention, and executive function, as assessed by cognitive function scales. This may be due to Semax's multiple mechanisms of action, which reduce neuronal damage, promote neural repair and regeneration, and thereby improve patients' cognitive function.

Cognitive Enhancement in Healthy Populations: In addition to addressing cognitive impairments in disease states, Semax may also have cognitive-enhancing effects in healthy populations. With the accelerating pace of modern life and increasing work-related stress, there is growing demand for enhancing cognitive abilities. Some studies have explored the effects of Semax in healthy volunteers. For example, in a study involving healthy adults, cognitive tests conducted after administering Semax to participants revealed improvements in attention, working memory, and information processing speed. This suggests that Semax may serve as a “smart drug” to help healthy individuals enhance cognitive performance in specific situations, such as preparing for exams or handling high-intensity work.

Current Status and Prospects of Semax Research

Current Status: Currently, research on Semax has achieved certain results. In basic research, its mechanism of action has been relatively well understood; in preclinical studies, its cognitive-enhancing effects in animal models have been confirmed; and in clinical studies, it has shown preliminary potential in treating cognitive disorders.

Conclusion

In summary, neuropeptide Semax, as a substance with potential cognitive-enhancing effects, has demonstrated efficacy in both basic research and clinical applications.

Sources

[1] Glazova N Y, Manchenko D M, Vilensky D A, et al. Effects of Semax in the Rat Models of Acute Stress[J]. Journal of Evolutionary Biochemistry and Physiology, 2023,59(1):200-212.DOI:10.1134/S0022093023010179.

[2] Hadarceva K, Belyaeva E. SEMAX - APPLICATION PROSPECTS (brief overview message)[J]. Clinical Medicine and Pharmacology, 2021. https://api.semanticscholar.org/CorpusID:245468513

[3] Puspita R, Pratamastuti D, Safitri A, et al. The Potency of Semax Peptide Therapy toward MDA Level and Protein Profile in Epilepsy Rats (Rattus norvegicus), 2018[C]. https://api.semanticscholar.org/CorpusID:90160574

[4] Lebedeva I S, Panikratova Y R, Sokolov O Y, et al. Effects of Semax on the Default Mode Network of the Brain[J]. Bulletin of Experimental Biology and Medicine, 2018,165(5):653-656.DOI:10.1007/s10517-018-4234-3.

[5] Stavchansky V V, Yuzhakov V V, Botsina A Y, et al. The effect of Semax and its C-end peptide PGP on the morphology and proliferative  activity of rat brain cells during experimental ischemia: a pilot study[J]. Journal of Molecular Neuroscience, 2011,45(2):177-185.DOI:10.1007/s12031-010-9421-2.

[6] Timoshenko T V, Poletaeva I I, Pavlova G V, et al. Effect of neonatal injections of the neuropeptide Semax on cell proliferation in  hippocampal dentate area in rats of two genotypes[J]. Dokl Biol Sci, 2009,424:78-80.DOI:10.1134/s0012496609010232.

Product available for research use only: